ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260743.1	Ponatinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.020504859	Sensitive
ENSG00000260743.1	Ponatinib	Lung squamous cell carcinoma	0.002105474	Resistant